Refine by
697 results found
-
Racial Disparities in Schizophrenia Treatment with Clozapine
Despite the efficacy of the antipsychotic clozapine in treating schizophrenia, research suggests that its use is somewhat limited. This study investigates the role of demographic factors in this discrepancy.
-
Types of Jail-Based Mental Health Providers and Service Engagement after Re-Entry
After incarceration, it can be extremely difficult for people to stay connected to mental health services. A new study explores how different types of jail-based mental health providers may affect service engagement following release.
-
Regulatory Comment to NCQA on Maternal Mental Health and Research and Treatment Innovation
Comment in response to the National Committee for Quality Assurance (NCQA)’s 2024 request for public comment on HEDIS Perinatal Depression Screening Measures, urging NCQA to add anxiety screening to the measures, require mandatory reporting of the measures, and exclude screening by insurer/health plan staff. -
Regulatory Comment to NCQA on Crisis Services and Research and Treatment Innovation
Regulatory comment supporting the NCQA’s Proposed Changes to Existing HEDIS Measures: Follow-Up After Emergency Department Visit for Mental Illness (FUM) and Follow-Up After Hospitalization for Mental Illness (FUH), and providing additional recommendations to strengthen the measures, including guidance on follow-up care. -
Mental Illness And Substance Use During Pregnancy Rising
Mental illness and substance use during pregnancy may lead to adverse maternal and birth outcomes, and recent research highlights concerning trends for both risk factors. Based on analysis of 2012-2021 National Survey on Drug Use and Health data, the prevalence of any mental illness (AMI) and serious mental illness (SMI) among pregnant individuals has increased over the past decade, and the use of two or more substances (tobacco, alcohol or marijuana) has increased disproportionately among those with SMI. The researchers suggest compassionate, tailored strategies to best serve pregnant individuals with co-occurring mental illness and substance use. -
Letter to HHS and Domestic Policy Council on Health Coverage, Medicaid and Parity
Letter to HHS Secretary Becerra and Domestic Policy Council Director Tanden urging the prompt finalization of a number of pending rules that will greatly advance affordable, accessible, and adequate healthcare coverage. -
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health and Research and Treatment Innovation
Letter asking Senate HELP Committee to include the Preventing Adverse Childhood Experiences (PACE) Act in its reauthorization of the SUPPORT for Patients and Communities Act. -
Regulatory Comment to Department of Labor on Health Coverage
Regulatory comment to the Department of Labor, offering strong support to its proposal to rescind the 2018 “Definition of Employer—Association Health Plans” final rule. -
Impact Of Climate Disasters On Adolescent Mental Health
Climate change is a known public health concern, and recent research emphasizes the potential impact on youth mental health. Reviewing data from over 38,000 high school students in 22 urban public school districts across 14 states, researchers found that adolescents experiencing the greatest number of climate-related “disaster days” were more likely to experience mental distress when exposed within the past 2 or 5 years compared to those who experienced fewer disaster days. Notably, no significant association was found between mental distress and exposure to disaster days in the past 10 years or to individual disaster events. To learn more, see the study in Preventive Medicine Reports. -
New Research Into Blood-Based Prediction Of Psychosis Risk
Analyzing 10 years of blood samples from individuals receiving treatment for schizophrenia, schozoaffective disorder, bipolar disorder and major depressive disorder at a VA Medical Center, researchers recently identified biomarkers that predicted the experience of high levels of hallucinations and delusions, respectively. Notably, some of the identified biomarkers are targeted by existing medications, suggesting that biomarker-based treatment protocols may be able to offer more individualized pharmacological care than the typical trial-and-error approach. Further research is needed, but the study represents progress toward more objective diagnosis and treatment of psychosis conditions. To learn more, see the study in Molecular Biology and a summary in NIH Research Matters.